Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (141-150 of 384) with videos related to

Pageof 39
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 6, 2011
Pharmacogenetic and germline prognostic markers of lung cancerAnne M Horgan, Boming Yang, Abul Kalam Azad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic markerChang Qi Zhu, Fiona H Blackhall, Melania Pintilie, et al.
Clinical Lung Cancer|February 11, 2017
Evolution of Symptom Burden of Advanced Lung Cancer Over a DecadeMike R Sung, Milan V Patel, Sarvar Djalalov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancerRodryg Ramlau, Radj Gervais, Maciej Krzakowski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2012
Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Alexander Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2016
Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?Charles Lim, Mike Sung, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based ChemotherapyTracey L Evans, Byoung Chul Cho, Katalin Udud, et al.
Clinical Lung Cancer|June 18, 2015
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24Jair Bar, Keyue Ding, Huijun Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2017
EGFR Mutation Analysis for Prospective Patient Selection in Two Phase II Registration Studies of OsimertinibSuzanne Jenkins, James Chih-Hsin Yang, Pasi A Jänne, et al.
Hormones & Cancer|February 4, 2012
Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancerSri Navaratnam, Georgios Skliris, Gefei Qing, et al.
Pageof 39

Showing results (141-150 of 384) with videos related to

Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 6, 2011
Pharmacogenetic and germline prognostic markers of lung cancerAnne M Horgan, Boming Yang, Abul Kalam Azad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic markerChang Qi Zhu, Fiona H Blackhall, Melania Pintilie, et al.
Clinical Lung Cancer|February 11, 2017
Evolution of Symptom Burden of Advanced Lung Cancer Over a DecadeMike R Sung, Milan V Patel, Sarvar Djalalov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancerRodryg Ramlau, Radj Gervais, Maciej Krzakowski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2012
Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Alexander Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2016
Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?Charles Lim, Mike Sung, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based ChemotherapyTracey L Evans, Byoung Chul Cho, Katalin Udud, et al.
Clinical Lung Cancer|June 18, 2015
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24Jair Bar, Keyue Ding, Huijun Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2017
EGFR Mutation Analysis for Prospective Patient Selection in Two Phase II Registration Studies of OsimertinibSuzanne Jenkins, James Chih-Hsin Yang, Pasi A Jänne, et al.
Hormones & Cancer|February 4, 2012
Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancerSri Navaratnam, Georgios Skliris, Gefei Qing, et al.
Pageof 39